Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.
Identifieur interne : 000329 ( Main/Exploration ); précédent : 000328; suivant : 000330Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.
Auteurs : J. Puig-Barberà [Espagne] ; J. Díez-Domingo ; A. Arnedo-Pena ; M. Ruiz-García ; S. Pérez-Vilar ; J L Mic Esparza ; A. Belenguer-Varea ; C. Carratalá-Munuera ; V. Gil-Guillén ; H. Schwarz-ChavarriSource :
- Vaccine [ 1873-2518 ] ; 2012.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Espagne (épidémiologie), Facteurs de risque (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Hospitalisation (statistiques et données numériques), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Sujet âgé (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (MeSH), Études cas-témoins (MeSH), Études prospectives (MeSH).
- MESH :
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Hospitalisation, Vaccination.
- épidémiologie : Espagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Sujet âgé, Vaccins antigrippaux, Études cas-témoins, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Case-Control Studies (MeSH), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Influenza Vaccines (MeSH), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Prospective Studies (MeSH), Risk Factors (MeSH), Spain (epidemiology), Vaccination (statistics & numerical data), Young Adult (MeSH).
- MESH :
- chemical : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Hospitalization, Vaccination.
- Adolescent, Adult, Aged, Case-Control Studies, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Young Adult.
Abstract
INTRODUCTION
We estimated influenza vaccine effectiveness (IVE) to prevent laboratory-confirmed influenza-related hospitalizations in patients 18 years old or older during the 2010-2011 influenza season.
METHODS
We conducted a prospective case-control study in five hospitals, in Valencia, Spain. Study subjects were consecutive emergency hospitalizations for predefined conditions associated with an influenza-like illness episode <8 days before admission. Patients were considered immunized if vaccinated ≥14 days before influenza-like illness onset. Cases were those with a real time reverse transcriptase polymerase chain reaction (RT-PCR) positive for influenza and controls were RT-PCR positive for other respiratory viruses. Adjusted IVE was estimated as 100×(1-adjusted odds ratio). To account for indication bias we computed adjusted IVE for respiratory syncytial virus related hospitalizations.
RESULTS
Of 826 eligible hospitalized patients, 102 (12%) were influenza positive and considered cases, and 116 (14%) were positive for other respiratory viruses and considered controls. Adjusted IVE was 54% (95% confidence interval, 11-76%). By subgroup, adjusted IVE was 53% (4-77%) for those with high-risk conditions, 59% (16-79%) for those ≥60 years of age, and, 54% (4-79%) for those ≥60 years of age with high-risk conditions. No influenza vaccine effect was observed against respiratory syncytial virus related hospitalization.
CONCLUSION
Influenza vaccination was associated with a significant reduction on the risk of confirmed influenza hospitalization, irrespective of age and high-risk conditions.
DOI: 10.1016/j.vaccine.2012.07.006
PubMed: 22819720
PubMed Central: PMC7115682
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.</title><author><name sortKey="Puig Barbera, J" sort="Puig Barbera, J" uniqKey="Puig Barbera J" first="J" last="Puig-Barberà">J. Puig-Barberà</name><affiliation wicri:level="1"><nlm:affiliation>Centro Superior de Investigación en Salud Pública CSISP, Valencia, Spain. puig joa@gva.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Superior de Investigación en Salud Pública CSISP, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez-Domingo">J. Díez-Domingo</name></author><author><name sortKey="Arnedo Pena, A" sort="Arnedo Pena, A" uniqKey="Arnedo Pena A" first="A" last="Arnedo-Pena">A. Arnedo-Pena</name></author><author><name sortKey="Ruiz Garcia, M" sort="Ruiz Garcia, M" uniqKey="Ruiz Garcia M" first="M" last="Ruiz-García">M. Ruiz-García</name></author><author><name sortKey="Perez Vilar, S" sort="Perez Vilar, S" uniqKey="Perez Vilar S" first="S" last="Pérez-Vilar">S. Pérez-Vilar</name></author><author><name sortKey="Mic Esparza, J L" sort="Mic Esparza, J L" uniqKey="Mic Esparza J" first="J L" last="Mic Esparza">J L Mic Esparza</name></author><author><name sortKey="Belenguer Varea, A" sort="Belenguer Varea, A" uniqKey="Belenguer Varea A" first="A" last="Belenguer-Varea">A. Belenguer-Varea</name></author><author><name sortKey="Carratala Munuera, C" sort="Carratala Munuera, C" uniqKey="Carratala Munuera C" first="C" last="Carratalá-Munuera">C. Carratalá-Munuera</name></author><author><name sortKey="Gil Guillen, V" sort="Gil Guillen, V" uniqKey="Gil Guillen V" first="V" last="Gil-Guillén">V. Gil-Guillén</name></author><author><name sortKey="Schwarz Chavarri, H" sort="Schwarz Chavarri, H" uniqKey="Schwarz Chavarri H" first="H" last="Schwarz-Chavarri">H. Schwarz-Chavarri</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22819720</idno><idno type="pmid">22819720</idno><idno type="doi">10.1016/j.vaccine.2012.07.006</idno><idno type="pmc">PMC7115682</idno><idno type="wicri:Area/Main/Corpus">00287</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00287</idno><idno type="wicri:Area/Main/Curation">000287</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000287</idno><idno type="wicri:Area/Main/Exploration">000287</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.</title><author><name sortKey="Puig Barbera, J" sort="Puig Barbera, J" uniqKey="Puig Barbera J" first="J" last="Puig-Barberà">J. Puig-Barberà</name><affiliation wicri:level="1"><nlm:affiliation>Centro Superior de Investigación en Salud Pública CSISP, Valencia, Spain. puig joa@gva.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Superior de Investigación en Salud Pública CSISP, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez-Domingo">J. Díez-Domingo</name></author><author><name sortKey="Arnedo Pena, A" sort="Arnedo Pena, A" uniqKey="Arnedo Pena A" first="A" last="Arnedo-Pena">A. Arnedo-Pena</name></author><author><name sortKey="Ruiz Garcia, M" sort="Ruiz Garcia, M" uniqKey="Ruiz Garcia M" first="M" last="Ruiz-García">M. Ruiz-García</name></author><author><name sortKey="Perez Vilar, S" sort="Perez Vilar, S" uniqKey="Perez Vilar S" first="S" last="Pérez-Vilar">S. Pérez-Vilar</name></author><author><name sortKey="Mic Esparza, J L" sort="Mic Esparza, J L" uniqKey="Mic Esparza J" first="J L" last="Mic Esparza">J L Mic Esparza</name></author><author><name sortKey="Belenguer Varea, A" sort="Belenguer Varea, A" uniqKey="Belenguer Varea A" first="A" last="Belenguer-Varea">A. Belenguer-Varea</name></author><author><name sortKey="Carratala Munuera, C" sort="Carratala Munuera, C" uniqKey="Carratala Munuera C" first="C" last="Carratalá-Munuera">C. Carratalá-Munuera</name></author><author><name sortKey="Gil Guillen, V" sort="Gil Guillen, V" uniqKey="Gil Guillen V" first="V" last="Gil-Guillén">V. Gil-Guillén</name></author><author><name sortKey="Schwarz Chavarri, H" sort="Schwarz Chavarri, H" uniqKey="Schwarz Chavarri H" first="H" last="Schwarz-Chavarri">H. Schwarz-Chavarri</name></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Case-Control Studies (MeSH)</term><term>Female (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (MeSH)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Risk Factors (MeSH)</term><term>Spain (epidemiology)</term><term>Vaccination (statistics & numerical data)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Espagne (épidémiologie)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (MeSH)</term><term>Études cas-témoins (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Risk Factors</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Sujet âgé</term><term>Vaccins antigrippaux</term><term>Études cas-témoins</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>We estimated influenza vaccine effectiveness (IVE) to prevent laboratory-confirmed influenza-related hospitalizations in patients 18 years old or older during the 2010-2011 influenza season.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We conducted a prospective case-control study in five hospitals, in Valencia, Spain. Study subjects were consecutive emergency hospitalizations for predefined conditions associated with an influenza-like illness episode <8 days before admission. Patients were considered immunized if vaccinated ≥14 days before influenza-like illness onset. Cases were those with a real time reverse transcriptase polymerase chain reaction (RT-PCR) positive for influenza and controls were RT-PCR positive for other respiratory viruses. Adjusted IVE was estimated as 100×(1-adjusted odds ratio). To account for indication bias we computed adjusted IVE for respiratory syncytial virus related hospitalizations.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Of 826 eligible hospitalized patients, 102 (12%) were influenza positive and considered cases, and 116 (14%) were positive for other respiratory viruses and considered controls. Adjusted IVE was 54% (95% confidence interval, 11-76%). By subgroup, adjusted IVE was 53% (4-77%) for those with high-risk conditions, 59% (16-79%) for those ≥60 years of age, and, 54% (4-79%) for those ≥60 years of age with high-risk conditions. No influenza vaccine effect was observed against respiratory syncytial virus related hospitalization.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Influenza vaccination was associated with a significant reduction on the risk of confirmed influenza hospitalization, irrespective of age and high-risk conditions.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22819720</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>39</Issue><PubDate><Year>2012</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.</ArticleTitle><Pagination><MedlinePgn>5714-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2012.07.006</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We estimated influenza vaccine effectiveness (IVE) to prevent laboratory-confirmed influenza-related hospitalizations in patients 18 years old or older during the 2010-2011 influenza season.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a prospective case-control study in five hospitals, in Valencia, Spain. Study subjects were consecutive emergency hospitalizations for predefined conditions associated with an influenza-like illness episode <8 days before admission. Patients were considered immunized if vaccinated ≥14 days before influenza-like illness onset. Cases were those with a real time reverse transcriptase polymerase chain reaction (RT-PCR) positive for influenza and controls were RT-PCR positive for other respiratory viruses. Adjusted IVE was estimated as 100×(1-adjusted odds ratio). To account for indication bias we computed adjusted IVE for respiratory syncytial virus related hospitalizations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 826 eligible hospitalized patients, 102 (12%) were influenza positive and considered cases, and 116 (14%) were positive for other respiratory viruses and considered controls. Adjusted IVE was 54% (95% confidence interval, 11-76%). By subgroup, adjusted IVE was 53% (4-77%) for those with high-risk conditions, 59% (16-79%) for those ≥60 years of age, and, 54% (4-79%) for those ≥60 years of age with high-risk conditions. No influenza vaccine effect was observed against respiratory syncytial virus related hospitalization.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Influenza vaccination was associated with a significant reduction on the risk of confirmed influenza hospitalization, irrespective of age and high-risk conditions.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puig-Barberà</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Superior de Investigación en Salud Pública CSISP, Valencia, Spain. puig joa@gva.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díez-Domingo</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Arnedo-Pena</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ruiz-García</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pérez-Vilar</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Micó-Esparza</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Belenguer-Varea</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Carratalá-Munuera</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Gil-Guillén</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Schwarz-Chavarri</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>07</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22819720</ArticleId><ArticleId IdType="pii">S0264-410X(12)01007-9</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2012.07.006</ArticleId><ArticleId IdType="pmc">PMC7115682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Dis. 2000 Mar;181(3):831-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10720501</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Feb 04;15(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">20144443</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Nov 5;27(47):6546-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19729083</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1974 May;99(5):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">4825599</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Mar 1;50(5):747-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20121411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Aug 15;200(4):492-500</Citation><ArticleIdList><ArticleId IdType="pubmed">19591575</ArticleId></ArticleIdList></Reference><Reference><Citation>Aten Primaria. 2000 Mar 31;25(5):350-63</Citation><ArticleIdList><ArticleId IdType="pubmed">10905823</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Sep;47(9):2981-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19571031</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Apr 28;352(17):1749-59</Citation><ArticleIdList><ArticleId IdType="pubmed">15858184</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2008 Jul;46(7):2414-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18480225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2007 Jan;119(1):e70-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17130280</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2008 Dec 8;168(22):2489-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19064834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876</Citation><ArticleIdList><ArticleId IdType="pubmed">20166072</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2007 Jul;45(7):2260-2</Citation><ArticleIdList><ArticleId IdType="pubmed">17507513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Jan;12(1):5-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22032845</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 May 1;203(9):1309-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21378375</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 1999 Aug;28(4):764-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10480708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2010 Mar 5;85(10):81-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20210260</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Nov 15;29(49):9159-70</Citation><ArticleIdList><ArticleId IdType="pubmed">21840359</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Oct 28;333(7574):912-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17068038</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2011 Feb;30(2):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21079528</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 May 1;21(16):1776-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12686093</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Nov 3;28(47):7460-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20875486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2008 Sep;152(1-2):25-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18598722</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19918065</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Rev. 1995;17(2):243-64</Citation><ArticleIdList><ArticleId IdType="pubmed">8654510</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Oct 6;29(43):7320-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21810450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2007 Jul;45(7):2116-22</Citation><ArticleIdList><ArticleId IdType="pubmed">17475762</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Dec 7;272(21):1661-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7966893</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 Dec 2;23(3):283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15530669</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 1993 Dec;22(6):1189-92</Citation><ArticleIdList><ArticleId IdType="pubmed">8144304</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Jan 15;199(2):159-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19086915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2005 Aug 19;80(33):279-87</Citation><ArticleIdList><ArticleId IdType="pubmed">16171031</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Nov;15(11):1849-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19891883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22032844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Sep 28;25(39-40):6852-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17719149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Apr 1;28(16):2903-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20153351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Jun;47(6):1742-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19339471</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Sep;47(9):2772-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19641063</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Nov 05;14(44):</Citation><ArticleIdList><ArticleId IdType="pubmed">19941774</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 Feb 15;203(4):500-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21220776</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2011 Mar 17;16(11):</Citation><ArticleIdList><ArticleId IdType="pubmed">21435331</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Jan;8(1):e1000388</Citation><ArticleIdList><ArticleId IdType="pubmed">21379316</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Apr 06;7(4):e1000258</Citation><ArticleIdList><ArticleId IdType="pubmed">20386731</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jan 5;30(2):195-200</Citation><ArticleIdList><ArticleId IdType="pubmed">22100636</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Arnedo Pena, A" sort="Arnedo Pena, A" uniqKey="Arnedo Pena A" first="A" last="Arnedo-Pena">A. Arnedo-Pena</name><name sortKey="Belenguer Varea, A" sort="Belenguer Varea, A" uniqKey="Belenguer Varea A" first="A" last="Belenguer-Varea">A. Belenguer-Varea</name><name sortKey="Carratala Munuera, C" sort="Carratala Munuera, C" uniqKey="Carratala Munuera C" first="C" last="Carratalá-Munuera">C. Carratalá-Munuera</name><name sortKey="Diez Domingo, J" sort="Diez Domingo, J" uniqKey="Diez Domingo J" first="J" last="Díez-Domingo">J. Díez-Domingo</name><name sortKey="Gil Guillen, V" sort="Gil Guillen, V" uniqKey="Gil Guillen V" first="V" last="Gil-Guillén">V. Gil-Guillén</name><name sortKey="Mic Esparza, J L" sort="Mic Esparza, J L" uniqKey="Mic Esparza J" first="J L" last="Mic Esparza">J L Mic Esparza</name><name sortKey="Perez Vilar, S" sort="Perez Vilar, S" uniqKey="Perez Vilar S" first="S" last="Pérez-Vilar">S. Pérez-Vilar</name><name sortKey="Ruiz Garcia, M" sort="Ruiz Garcia, M" uniqKey="Ruiz Garcia M" first="M" last="Ruiz-García">M. Ruiz-García</name><name sortKey="Schwarz Chavarri, H" sort="Schwarz Chavarri, H" uniqKey="Schwarz Chavarri H" first="H" last="Schwarz-Chavarri">H. Schwarz-Chavarri</name></noCountry><country name="Espagne"><noRegion><name sortKey="Puig Barbera, J" sort="Puig Barbera, J" uniqKey="Puig Barbera J" first="J" last="Puig-Barberà">J. Puig-Barberà</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000329 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000329 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22819720
|texte= Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22819720" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |